It is known that VHL mutations can be widely detected in ccRCC; moreover, it has been suggested that VHL mutations might drive the activation of effector T cells as well as enhance cytokine level in ccRCC (35), indicating a potential but crucial role that immune infiltration might play. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.